← Insider buys

Scott T Reents has sold ABBV and made no open-market buys since Mar 2023

EVP and CFO at AbbVie Inc.

SEC CIK 0001937048 · Filings on SEC.gov ↗

$0Bought
$4.9MSold
NoneLast buy

Every filing

2 filings since Mar 2023, newest first

Filings come from SEC EDGAR. Not investment advice.